Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Venous Thrombolysis: Current Perspectives.

Jay Menon1, Mahmoud M. Salman, George Hamilton Md

  • 1University Department of Surgery, Royal Free Hospital, Royal Free and University College Medical School, UCL, Pond Street, London NW3 2QG, UK. G.hamilton@rfc.ucl.ac.uk

Current Treatment Options in Cardiovascular Medicine
|April 7, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epiploic Appendagitis Masquerading as Acute Appendicitis: A Report of Two Cases.

Cureus·2020
Same author

The Challenge of COVID-19: The Biological Characteristics and Outcomes in a Series of 130 Breast Cancer Patients Operated on During the Pandemic.

Chirurgia (Bucharest, Romania : 1990)·2020
Same author

Cataract surgery planning in amblyopic patients--which eye first? Awareness of the potential for post-operative diplopia amongst consultant ophthalmic surgeons in Wales.

The Ulster medical journal·2013
Same author

Inflammatory abdominal aortic aneurysm: a persistent painful hip.

BMJ case reports·2013
Same author

Sudden loss of vision in a patient with significant ipsilateral internal carotid disease.

BMJ case reports·2012
Same author

Abdominal aortic aneurysm secondary to infection with Pseudomonas aeruginosa: a rare cause of mycotic aneurysm.

Annals of vascular surgery·2010
Same journal

An Update on the Role of Renal Artery Denervation in the Treatment of Hypertension.

Current treatment options in cardiovascular medicine·2026
Same journal

Advancements and Challenges in Contemporizing Care for Adult Patients with Congenital Heart Disease and Advanced Heart Failure: An Update on Application of Modern Heart Failure Technologies.

Current treatment options in cardiovascular medicine·2026
Same journal

Evolving Decongestion Strategies in the Management of Acute Heart Failure.

Current treatment options in cardiovascular medicine·2025
Same journal

Advanced Electroanatomic Mapping: Current and Emerging Approaches.

Current treatment options in cardiovascular medicine·2025
Same journal

Metabolic Reprogramming in Heart Failure: From Energy Starvation to Therapeutic Targets.

Current treatment options in cardiovascular medicine·2025
Same journal

Drug-Coated Balloons for Coronary Artery Disease: From Theory to Practice.

Current treatment options in cardiovascular medicine·2025
See all related articles

Venous thromboembolism (VTE) is a common cardiovascular disease. While anticoagulation is standard, new thrombolytic therapies show promise for specific patient groups, though their role is still being explored.

Area of Science:

  • Cardiovascular Medicine
  • Hematology

Background:

  • Venous thromboembolism (VTE) is a prevalent condition impacting hospital and community patients.
  • VTE is the third leading cause of cardiovascular disease, following ischemic heart disease and stroke.
  • It significantly contributes to prolonged hospital stays, morbidity, and mortality.

Purpose of the Study:

  • To review the current understanding and emerging roles of thrombolysis in treating venous thrombosis.
  • To identify patient populations that may benefit from primary thrombolytic therapy.

Main Methods:

  • Literature review of traditional treatments and novel thrombolytic approaches for venous thrombosis.
  • Analysis of reported outcomes and challenges associated with systemic and catheter-directed thrombolysis.

Related Experiment Videos

Main Results:

  • Anticoagulation with heparin and warfarin remains the traditional treatment for venous thrombosis.
  • Thrombolytic therapy, including catheter-directed methods, shows promising results.
  • Systemic thrombolysis carries risks such as catheter fragmentation.

Conclusions:

  • The precise role of thrombolysis in venous thrombosis management is still under investigation.
  • Identifying specific patient groups for primary thrombolytic treatment is an ongoing area of research.
  • Emerging data suggest thrombolysis may offer a valuable alternative or adjunct treatment in select VTE cases.